179 related articles for article (PubMed ID: 37038134)
1. European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention-part 1: amitriptyline.
Lampl C; Versijpt J; Amin FM; Deligianni CI; Gil-Gouveia R; Jassal T; MaassenVanDenBrink A; Ornello R; Paungarttner J; Sanchez-Del-Rio M; Reuter U; Uluduz D; de Vries T; Zeraatkar D; Sacco S
J Headache Pain; 2023 Apr; 24(1):39. PubMed ID: 37038134
[TBL] [Abstract][Full Text] [Related]
2. European Headache Federation (EHF) critical reappraisal and meta-analysis of oral drugs in migraine prevention - part 3: topiramate.
Raffaelli B; García-Azorín D; Boucherie DM; Amin FM; Deligianni CI; Gil-Gouveia R; Kirsh S; Lampl C; Sacco S; Uluduz D; Versijpt J; MaassenVanDenBrink A; Zeraatkar D; Sanchez-Del-Rio M; Reuter U
J Headache Pain; 2023 Oct; 24(1):134. PubMed ID: 37814223
[TBL] [Abstract][Full Text] [Related]
3. European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention-part 2: flunarizine.
Deligianni CI; Sacco S; Ekizoglu E; Uluduz D; Gil-Gouveia R; MaassenVanDenBrink A; Ornello R; Sanchez-Del-Rio M; Reuter U; Versijpt J; de Vries T; Hussain M; Zeraatkar D; Lampl C
J Headache Pain; 2023 Sep; 24(1):128. PubMed ID: 37723437
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxins for the prevention of migraine in adults.
Herd CP; Tomlinson CL; Rick C; Scotton WJ; Edwards J; Ives N; Clarke CE; Sinclair A
Cochrane Database Syst Rev; 2018 Jun; 6(6):CD011616. PubMed ID: 29939406
[TBL] [Abstract][Full Text] [Related]
6. The comparative effectiveness of migraine preventive drugs: a systematic review and network meta-analysis.
Lampl C; MaassenVanDenBrink A; Deligianni CI; Gil-Gouveia R; Jassal T; Sanchez-Del-Rio M; Reuter U; Uluduz D; Versijpt J; Zeraatkar D; Sacco S
J Headache Pain; 2023 May; 24(1):56. PubMed ID: 37208596
[TBL] [Abstract][Full Text] [Related]
7. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults.
Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
Cochrane Database Syst Rev; 2015 Apr; 4(4):CD002919. PubMed ID: 25829028
[TBL] [Abstract][Full Text] [Related]
8. Acupuncture for the prevention of episodic migraine.
Linde K; Allais G; Brinkhaus B; Fei Y; Mehring M; Vertosick EA; Vickers A; White AR
Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD001218. PubMed ID: 27351677
[TBL] [Abstract][Full Text] [Related]
9. Efficacy, Safety, and Acceptability of Pharmacologic Treatments for Pediatric Migraine Prophylaxis: A Systematic Review and Network Meta-analysis.
Locher C; Kossowsky J; Koechlin H; Lam TL; Barthel J; Berde CB; Gaab J; Schwarzer G; Linde K; Meissner K
JAMA Pediatr; 2020 Apr; 174(4):341-349. PubMed ID: 32040139
[TBL] [Abstract][Full Text] [Related]
10. Endogenous Melatonin Levels and Therapeutic Use of Exogenous Melatonin in Migraine: Systematic Review and Meta-Analysis.
Liampas I; Siokas V; Brotis A; Vikelis M; Dardiotis E
Headache; 2020 Jul; 60(7):1273-1299. PubMed ID: 32352572
[TBL] [Abstract][Full Text] [Related]
11. Antiepileptics other than gabapentin, pregabalin, topiramate, and valproate for the prophylaxis of episodic migraine in adults.
Linde M; Mulleners WM; Chronicle EP; McCrory DC
Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD010608. PubMed ID: 23797674
[TBL] [Abstract][Full Text] [Related]
12. Psychological therapies for the prevention of migraine in adults.
Sharpe L; Dudeney J; Williams ACC; Nicholas M; McPhee I; Baillie A; Welgampola M; McGuire B
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD012295. PubMed ID: 31264211
[TBL] [Abstract][Full Text] [Related]
13. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.
Dodick DW; Freitag F; Banks J; Saper J; Xiang J; Rupnow M; Biondi D; Greenberg SJ; Hulihan J;
Clin Ther; 2009 Mar; 31(3):542-59. PubMed ID: 19393844
[TBL] [Abstract][Full Text] [Related]
14. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults.
Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
Cochrane Database Syst Rev; 2015 May; 2015(5):CD011681. PubMed ID: 25931277
[TBL] [Abstract][Full Text] [Related]
15. Drugs for preventing migraine headaches in children.
Victor S; Ryan SW
Cochrane Database Syst Rev; 2003; (4):CD002761. PubMed ID: 14583952
[TBL] [Abstract][Full Text] [Related]
16. A Randomized Controlled Trial of High Rate rTMS Versus rTMS and Amitriptyline in Chronic Migraine.
Kalita J; Kumar S; Singh VK; Misra UK
Pain Physician; 2021 Sep; 24(6):E733-E741. PubMed ID: 34554691
[TBL] [Abstract][Full Text] [Related]
17. Migraine prophylactic drugs: proof of efficacy, utilization and cost.
Ramadan NM; Schultz LL; Gilkey SJ
Cephalalgia; 1997 Apr; 17(2):73-80. PubMed ID: 9137841
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin A for prophylactic treatment of migraine and tension headaches in adults: a meta-analysis.
Jackson JL; Kuriyama A; Hayashino Y
JAMA; 2012 Apr; 307(16):1736-45. PubMed ID: 22535858
[TBL] [Abstract][Full Text] [Related]
19. Unveiling the relative efficacy, safety and tolerability of prophylactic medications for migraine: pairwise and network-meta analysis.
He A; Song D; Zhang L; Li C
J Headache Pain; 2017 Dec; 18(1):26. PubMed ID: 28220376
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
